Your browser doesn't support javascript.
loading
Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3- mutated acute myeloid leukemia patients - Czech center experience.
Weinbergerová, Barbora; Cernan, Martin; Kabut, Tomás; Semerád, Lukás; Podstavková, Natália; Szotkowski, Tomás; Jezísková, Ivana; Mayer, Jirí.
Afiliação
  • Weinbergerová B; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic. Weinbergerova.Barbora@fnbrno.cz.
  • Cernan M; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
  • Kabut T; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Semerád L; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Podstavková N; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Szotkowski T; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
  • Jezísková I; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Mayer J; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Haematologica ; 108(10): 2826-2829, 2023 10 01.
Article em En | MEDLINE | ID: mdl-36815379
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article País de afiliação: República Tcheca
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article País de afiliação: República Tcheca